Abstract-The effect of the combination of aminopyrine and secobarbital at a molar ratio of 2:1, the mixture and molecular compound, on rabbit EEG activation was examined. Secobarbital 40 mg/kg p.o. elevated threshold voltages in the neocortical and hippocampal EEG activation by high frequency electrical stimulation of the midbrain reticular formation (MRF), nucleous centralis medialis (CM) of the thalamus, and posterior hypothalamus (PHA) by 40, 40 and 80 %, respectively. Aminopyrine 80 mg/kg p.o. alone did not affect the arousal responses . The molecular compound 120 mg/kg p.o. has more potent and long-lasting actions in inhibiting the arousal responses induced by the stimulation of MRF (80%) and CM (50%) than with seco barbital alone. The inhibitory action of the mixture 120 mg/kg p.o. on the PHA arousal response (40 %) was significantly weaker than that of the molecular compound (80%). Secobarbital and the molecular compound slightly inhibited the neocortical augmenting and recruiting responses. Our findings suggest that although aminopyrine exerts a synergistic effect with secobarbital in inhibiting the EEG activation produced by MRF stimulation, in inhibiting the PHA-arousal response, there is no synergistic effect of the two drugs when they were given as the mixture. Moreover, the molecular compound rather than the mixture has a more potent inhibitory action on the EEG activation, particularly with PHA stimulation.
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Aminopyrine shows analgesic effects, although it has excitatory actions on the central nervous system (1) . One of the barbiturates, secobarbital , is a short-acting hypnotic.
The combination of the two drugs exhibits strong analgesic actions similarly to the combi nation of aminopyrine and barbital (2) . In fact, we have unpublished data showing that when 2 molar aminopyrine and 1 molar secobarbital were simultaneously given p .o. as the mixture, they showed more potent analgesic effects than each of these drugs , and that the combination consisting of the molecular compound in which aminopyrine was linked by a hydrogen bond to secobarbital at the molar ratio of 1:1 and another 1 molar aminopyrine, exerted more potent analgesic actions than the mixture.
A potentiation of analgesic action by the combination may be due to the finding that aminopyrine affects the absorption and metabolism of secobarbital (3, 4) , resulting in high blood levels of these drugs. However, there is no precise electrophysiological analysis on the action sites of the combination of aminopyrine and secobarbital in the brain.
The present investigation was designed to determine the sites and mode of actions of these combinations in the rabbit brain using the EEG technique.
MATERIALS AND METHODS
The drugs used in this experiment were as follows: aminopyrine (Maruko Pharmaceu tical Co., Tokyo), secobarbital, the mixture, and molecular compound. Secobarbital and the molecular compound were gifts from Grelan Pharmaceutical Co., Tokyo. The molecular compound consisted of aminopyrine and secobarbital at the molar ratio of 1:1. In a previous report we showed that the combination of these two drugs is the best at the molar ratio of 2:1 in experimental analgesic and toxic effects among various molar ratio (4). Therefore, another 1 molar of aminopyrine was added to 1 molar of the molecular compound, and this combination was refered to a the molecular compound, in the present report. Another combination, the mixture, consisted of 2 molar aminopyrine and 1 molar secobarbital. The drugs of four groups were suspended in 0.5 % carboxymethyl cellulose just before adminis tration, and the suspension was given p.o. to chronically electrode-implanted rabbits which had been fasting for 24 hours.
White male rabbits weighing 2.5 to 3.5 kg were anesthetized with sodium pentobarbital The electrodes were connected to the connector socket which was fixed with dental cement on the skull. Iodine tincture was applied on the operated region and 100,000 units of penicillin were injected i.m. once a day for three days after operation. The animals were used in the experiments at least a week after operation.
The EEG was recorded using a polygraph recorder (Nihon Kohden , RM-45), and 
DISCUSSION
The molecular compounds linked by hydrogen bond, pyrabital (barbital and amino pyrine) and secopyrabital (secobarbital and aminopyrine) used in this present report, had been considered to dissociate easily into the individual drugs in aqueous solution (7) . The dissociation may, however, occur completely when a molecular compound is suspended in a solution of carboxymethyl cellulose, but a complex of aminopyrine and secobarbital may be formed in an aqueous solution when they are dissolved simultaneously (8) . Thus, the effects of the chemical difference between the mixture and molecular compound in the stomach are unknown.
In the present report, we demonstrated pharmacologically a difference in inhibition of the EEG activation produced by electrical stimulation of particularly PHA among amino pyrine, secobarbital and their combinations. The inhibitory action of the mixture on the PHA-arousal response was weaker than that of secobarbital alone and the molecular com pound. A similar pattern was found in the neocortical augmenting response. This may be due to the finding that the inhibitory action of the mixture on the PHA-arousal response is decreased by the excitatory effect of aminopyrine. Therefore, aminopyrine may decrease the inhibitory actions of secobarbital on the EEG activation and neocortical augmenting response when given in combination with secobarbital.
The molecular compound had a significantly more potent action in inhibiting the PHA-arousal response than the mixture. If the molecular compound had been dissociated easily into the individual drugs in the stomach, similar inhibitory effects would have been apparent with both the molecular compound and the mixture. Therefore, we assume that the molecular compound itself is absorbed and then affects the PHA-arousal response .
In our previous report (4), the molecular compound of aminopyrine and secobarbital was shown to inhibit the writhing response induced by acetic acid in mice and the pseudo-affective responses induced by bradykinin in rats more strongly than the mixture. These findings may be explicable by the difference in inhibitory action to the PHA-arousal response between the molecular compound and the mixture. The molecular compound inhibited the EEG activation by electrical stimulation in the order of PHA, MRF and CM. Since the PHA is a region with an incomplete bloodbrain barrier, the transport of the molecular compound to PHA appears to be faster than that to the other brain regions. This may explain the potent inhibitory action of the molecular compound, the mixture and secobarbital alone on the PHA-arousal response.
Aminopyrine was shown to have a biphasic effect on the central nervous system. Ban (9) has shown that aminopyrine 50 mg/kg i.v. inhibits a neocortical recruiting response and elevates the threshold voltage required for the EEG activation by MRF stimulation. We did, however, detect a slightly excitatory effect rather than inhibitory actions of aminopyrine In conclusion, the inhibitory actions of the combination of aminopyrine and secobarbital to EEG activation may probably be based on those of secobarbital, and there is a statistically significant difference in inhibition of the PHA-arousal response, in particular between the molecular compound and mixture.
